Peer-reviewed veterinary case report
Stem cell therapy for bone and joint problems in dogs
By Banu, S Amitha et al.·Published in Veterinary research communications·2025·Amrita Research Centre, India·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Mesenchymal stem cell therapy in veterinary orthopaedics: Evidence from canine clinical medicine.
- Species:
- dog
Plain-English summary
A group of dogs with various orthopedic issues, like fractures and joint problems, were treated with mesenchymal stem cell (MSC) therapy to help with healing and pain relief. This treatment showed promising results, improving mobility and recovery in many cases. The MSCs helped repair tissues and reduce inflammation, making them a potential alternative to traditional therapies. While there are still challenges in standardizing treatment protocols, the positive outcomes from clinical trials suggest that MSC therapy could be a valuable option for dogs suffering from orthopedic conditions.
People also search for: dog joint pain treatment · mesenchymal stem cell therapy for dogs · dog fracture recovery options
Abstract
Mesenchymal stem cell (MSC) therapy is a promising approach for treating orthopaedic conditions in veterinary clinical patients. MSCs exhibit remarkable regenerative properties, including multilineage differentiation, immunomodulation, and tissue repair, making them an attractive alternative to conventional therapies. This comprehensive review explores the clinical potential of MSCs in managing a range of canine orthopaedic disorders, including fractures, degenerative joint diseases, and tendon injuries. Evidence from canine clinical studies highlights the ability of MSCs to enhance tissue healing, reduce pain, and restore function, offering valuable insights into their therapeutic utility. Optimizing delivery methods, such as intra-articular injections and scaffold-based approaches, is critical for maximizing therapeutic efficacy. Clinical trials in dogs have shown significant improvements in mobility and recovery, underscoring the relevance of MSC therapy for specific orthopaedic applications. Despite its potential, MSC therapy faces several challenges. One major hurdle is study heterogeneity, which complicates evidence synthesis. Differences in cell sourcing, dosage, and injection frequency make it difficult to establish a consensus on optimal treatment protocols. Future advancements should focus on expanding cell-free approaches utilizing MSC-derived bioactive molecules and extracellular vesicles. Furthermore, collaborative efforts between veterinarians, researchers, and industry partners will be critical in translating preclinical findings into viable commercial veterinary stem cell products. Large-scale, randomized clinical trials with standardized methodologies are necessary to validate the efficacy of MSC therapy across different orthopaedic conditions.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40875146/